Invivyd (IVVD) Cash from Investing Activities (2021 - 2025)
Invivyd (IVVD) reported Cash from Investing Activities of -$11000.0 for Q2 2025, up 92.36% quarter-over-quarter from -$144000.0 in Q1 2025.
Invivyd (IVVD) Cash from Investing Activities (2021 - 2025) Analysis & Trends
Invivyd has reported Cash from Investing Activities for 5 years, with the latest figure at -$11000.0 in Q2 2025.
- For the quarter ending Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$11000.0; the trailing twelve-month figure through Dec 2025 stood at -$155000.0 (down 10.71% YoY), and the FY2025 full-year result was -$155000.0, down 10.71% from the prior year.
- Cash from Investing Activities for Q2 2025 stood at -$11000.0, up from -$144000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $137.9 million in Q4 2021, with the low at -$188.6 million in Q3 2021.
- Historically, Cash from Investing Activities has averaged -$65933.3 across 5 years, with a median of -$5000.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 200.65% — and 2023, when it soared 191835.29%.
- Invivyd's Cash from Investing Activities stood at $137.9 million in 2021, then slumped by 200.65% to -$138.8 million in 2022, then surged by 156.13% to $77.9 million in 2023, then plunged by 99.99% to $5000.0 in 2024, then sank by 320.0% to -$11000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$11000.0 (Q2 2025), -$144000.0 (Q1 2025), and $5000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 579,519.10 |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -11,000.00 |
| Jun 30, 2025 | -11,000.00 |
| Mar 31, 2025 | -144,000.00 |
| Mar 31, 2025 | -144,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -140,000.00 |
| Mar 31, 2024 | -140,000.00 |
| Dec 31, 2023 | 77.92 Mn |
| Dec 31, 2023 | 77.92 Mn |
| Sep 30, 2023 | 95.14 Mn |
| Sep 30, 2023 | 95.14 Mn |
| Jun 30, 2023 | 32.60 Mn |
| Jun 30, 2023 | 32.60 Mn |
| Mar 31, 2023 | 75.04 Mn |
| Mar 31, 2023 | 75.04 Mn |
| Dec 31, 2022 | -138.81 Mn |
| Dec 31, 2022 | -138.81 Mn |